ClinicalTrials.gov
public full text
Public Domain
Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma
RATIONALE: Nicotine may stimulate the immune system to kill Kaposi's sarcoma cells. PURPOSE: This phase II trial is studying the side effects and how well the nicotine skin patch works in treating patients with Kaposi's sarcoma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants#851341
- Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement Products#1101479
- Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product#827621
- A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence#842280
- Pharmacokinetics and Acute Effects of Multiple Dose of Nicotine: Electronic Cigarette and Cigarette#967674
Record · ID 804509
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive